Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Mibe pharma UK Ltd, 4 Coleman Street, 6th Floor, London, EC2R 5AR, United Kingdom
Myopridin 3 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round tablet with a score line on one side. Diameter: 9.0 – 9.2 mm. The tablet can be divided into equal doses. |
One tablet contains 3.02 mg pridinol (as 4 mg pridinol mesilate).
Excipient(s) with known effect: One tablet contains 143.5 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Pridinol |
Pridinol is a piperidin- polyalcohol derivative with the chemical formula 1,1-Diphenyl-1-ol-3-piperidin-propan-methanesulfonate. Its pharmacological effect develops via an atropine-like mechanism that acts on both smooth and the striated muscles. This effect is used for the treatment of skeletal muscle tension of both central and peripheral origin. |
| List of Excipients |
|---|
|
Lactose monohydrate |
PVC//Al blisters.
Packs with 20, 50 and 100 tablets.
Hospital packs with 200 (10 × 20), 500 (10 × 50) and 1000 (10 × 100) tablets
Not all pack sizes may be marketed.
Mibe pharma UK Ltd, 4 Coleman Street, 6th Floor, London, EC2R 5AR, United Kingdom
PL 49452/0010
28/05/2020
| Drug | Countries | |
|---|---|---|
| MYOPRIDIN | Austria, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
